LMKC
MRNA icon

L.M. Kohn & Company’s Moderna MRNA Stock Holding History

L.M. Kohn & Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,426
Closed -$219K – 247
2023
Q1 		$219K Hold
1,426
– – 0.09% 194
2022
Q4 		$256K Buy
+1,426
New +$233K 0.12% 177
2022
Q3 		– Sell
-1,686
Closed -$241K – 228
2022
Q2 		$241K Sell
1,686
-139
-8% -$19.9K 0.11% 190
2022
Q1 		$315K Buy
+1,825
New +$307K 0.12% 183

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

L.M. Kohn & Company's MRNA Position: Q2 2023 in Review

L.M. Kohn & Company sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,426 shares — an estimated $219K sold.

L.M. Kohn & Company first reported a position in MRNA in Q1 2022 and held it in 4 quarters. The position peaked at $315K in Q1 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • L.M. Kohn & Company reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • L.M. Kohn & Company sold 1,426 Moderna shares in Q2 2023, an estimated $219K.
  • L.M. Kohn & Company first reported a position in Moderna in Q1 2022 and held it in 4 quarters.
  • L.M. Kohn & Company's Moderna position peaked at $315K in Q1 2022.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on L.M. Kohn & Company's 13F filing for Q2 2023, filed 8 Aug 2023.